Nevertheless, homes in the region are still selling at a record median price.
latest articles
Instead of prescribing an opioid-based treatment plan, the Intellis system offers doctors a non-opioid approach to treating chronic back pain.
The biotechnology company officially kicked off its IPO on Wednesday.
The long-time president of the Timberwolves and Lynx organization will officially make the transition to Minnesota United on October 6.
But don’t bust out the party hats just yet.
The latest generation is entering the workforce—and emerging as a powerful group of consumers.
The increase in the state’s unemployment rate was partially attributed to an overestimation of the state’s job growth in July.
The Revenue Department will have less than three weeks to respond to the technology company.
The Commerce Department concluded that no new pipeline capacity is needed to ensure “future adequacy, reliability and efficiency of energy supply.”
Redevelopment is nowhere near getting started.
U of M spinoff has tech to analyze microbial communities for health, ag clients.
Manufactured ‘XNA’ can bind to proteins that regulate cardiac function.
Percentage of state residents without health coverage less than half the national rate.
But he called the goal of single payer an "aspirational" one.
The startup’s personalized medicine test offers a unique potential in Asia, where people take similar medications to Americans and Europeans but don’t share the same genetic makeup.
The deal, according to an analyst at Leerink, would cost the Minnetonka-based insurer roughly $2.8 billion if completed.